Recent News

By Category: Public Health

Finding On Killer Cells Opens New Avenue For Combating AIDS, Cancer And Other Diseases

(Medical News Today) A research team led by the La Jolla Institute for Allergy & Immunology has discovered the mechanism that enables CD4 helper T cells to assume the more aggressive role of killer T cells in mounting an immune attack against viruses, cancerous tumors and other damaged or infected cells. The finding, made in Read More »

January 22, 2013
| Filed under North America, Agents & Toxins, Public Health, and Research
Share

Dengue epidemic in Southwest Brazil, Campo Grande in a ‘State of Emergency’ – The Global Dispatch

Dengue epidemic in Southwest Brazil, Campo Grande in a 'State of Emergency'The Global DispatchThere are three types of dengue fever in order of less severe to most: the typical uncomplicated dengue fever, dengue hemorrhagic fever (DHS) and dengue shock syndrome (DSS). The symptoms of classic dengue usually start within a week after being …

January 22, 2013
| Filed under Public Health
Share

FDA approves new seasonal influenza vaccine

(FDA) The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age. Unlike current flu vaccines, Flublok does not Read More »

January 17, 2013
| Filed under North America, Agents & Toxins, and Public Health
Share

Integrated neglected tropical disease control and elimination programs: A global health ‘best buy’

(EurekaAlert) A recently released report, entitled “Social and Economic Impact Review on Neglected Tropical Diseases,” highlights links between neglected tropical diseases (NTDs) and socio-economic prosperity. Published by Hudson Institute’s Center for Science in Public Policy, in partnership with the Global Network for Neglected Tropical Diseases, an initiative of the Sabin Vaccine Institute, the paper found Read More »

January 17, 2013
| Filed under North America, Agents & Toxins, International, Policy & Initiatives, and Public Health
Share

Major step toward an Alzheimer’s vaccine

(ScienceDaily) A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain’s natural defense mechanisms in people with Alzheimer’s disease. This major breakthrough, details of which are presented January 15 in an early online edition of the Proceedings of the National Academy of Read More »